2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Acute Myeloblastic Leukemia: new trials by email Literature Review of Acute Myeloblastic Leukemia trials Research Report on Acute Myeloblastic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Yttrium-90 Anti CD66 Monoclonal Antibody in Childhood Relapsed/Refractory Leukaemia Yttrium-90 labelled monoclonal antibody against CD66 - Acute Myeloblastic Leukemia, Acute Lymphoblastic Leukemia | Phase 1 | Completed | Great Ormond Street Hospital for Children NHS Foundation Trust | 9 | 2016-05-01 | 2021-06-25 |
| Treatment of Relapsed or Refractory Acute Myeloblastic Leukemia fludarabine, Idarubicin, cytarabine - Acute Myeloblastic Leukemia | Phase 1 / Phase 2 | Completed | PETHEMA Foundation | 55 | 2012-07-01 | 2017-04-25 |
Leukemia, Myeloid, Acute (2) · Leukemia, Myelomonocytic, Juvenile (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Leukemia (2) · Leukemia, Myeloid (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Bone Marrow Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Myelodysplastic-Myeloproliferative Diseases (1)
Cytarabine (1) · Granulocyte Colony-Stimulating Factor (1) · Idarubicin (1) · Radioimmunotherapy (1) · fludarabine (1) · plerixafor (1)
Great Ormond Street Hospital for Children NHS Foundation Trust (1) · PETHEMA Foundation (1)
Spain (1) · United Kingdom (1)